Nana Li

Nana Li

Auto-generated profile, based on publicly available information

Nana Li

Department of Clinical Laboratory Harbin Medical University Cancer Hospital Harbin China

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2022 in Cancer Letters
Verified
Journal Article
Closed access
JXJiali Xu
Jiali Xu
LZLiren Zhang
Liren Zhang
NLNana Li
Nana Li
JDJingjing Dai
Jingjing Dai
RZRuizhi Zhang
Ruizhi Zhang
CLCunming Liu
Cunming Liu

19 December 2024 in Journal of Cell Communication and Signaling
Verified
Journal Article
Open access
NLNana Li
Nana Li
PYPeihua Yan
Peihua Yan
LGLing Guo
Ling Guo
HWHuiyan Wang
Huiyan Wang
BCBaohong Cui
Baohong Cui
YSyajuan su
yajuan su
Chemo‐resistance in ovarian cancer is currently a major obstacle to the treatment and recovery of ovarian cancer. Therefore, identifying factors associated with chemo‐resistance in ovarian cancer may reverse chemo‐sensitization. Using isobaric tags for relative and absolute quantitation (ITRAQ) technology, we found a small molecule peptide with annexin 1 (ANXA1) as a precursor protein. Then, we explored the effects and mechanisms of this small molecule peptide on the proliferation, apoptosis, and drug resistance of ovarian cancer resistant cells through CCK‐8, EdU cell proliferation assay, Annexin V‐FITC/PI assay, Western blot,qRT‐PCR. ANXA114‐26 was highly expressed in the serums of sensitive patients. ANXA114‐26 promoted apoptosis of ovarian cancer cells and increased the sensitization of ovarian cancer cells to cisplatin. The ANXA114‐26 and ANXA1 competitively bind formyl peptide receptors (FPR). ANXA114‐26 decreased multidrug resistance‐associated protein 1 (MRP1) expression in ovarian cancer cells through the FPR/Cyclin D1/NF‐ĸBp65 pathway. We found a peptide derived named ANXA114‐26 in the serum of ovarian cancer patients. It can reduce ovarian cancer cell proliferation and reduce MRP1 expression through the FPR/Cyclin D1/NF‐ĸBp65 pathway.

13 April 2022 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
RZRuijie Zhang
Ruijie Zhang
PLPeng Li
Peng Li
HLHeli Lv
Heli Lv
NLNana Li
Nana Li
SRSuliang Ren
Suliang Ren
WXWentao Xu
Wentao Xu

1 June 2012
Verified
Journal Article
Closed access
YLYan-Li Li
Yan-Li Li
NLNa-Na Li
Na-Na Li
YWYan-Ping Wang
Yan-Ping Wang
MLMing-Rong Li
Ming-Rong Li
LDLi Dai
Li Dai
JZJun Zhu
Jun Zhu
To analyze potential mutation of keration 9 gene (KRT9) in a Chinese family affected with epidermolytic palmoplantar keratoderma (EPPK) and to correlate genotype with the phenotype. Genomic DNA was extracted from peripheral blood samples of 12 patients and 13 healthy individuals from the family and 100 unrelated individuals. Polymerase chain reaction (PCR) was used to amplify exons 1 and 6 of KRT9 gene. PCR products were sequenced bidirectionally in order to identify potential mutations. A heterozygous transversional mutation, 488G→A, was identified in exon 1 of KRT9 gene in all patients, which has resulted in substitution of a glutamine residue for arginine acid at position 163 (R163Q) of the KRT9 protein. The same mutation was not found in the 13 healthy members from the family and 100 unrelated individuals. The 488G→A mutation of KRT9 gene is probably the cause of EPPK in this Chinese family.

16 June 2020 in Journal of Bio-X Research
Verified
Journal Article
Open access
HDHaibo Du
Haibo Du
NLNana Li
Nana Li
ZXZhigang Xu
Zhigang Xu
Myosins comprise a large superfamily of adenosine triphosphatases (ATPases) that interact with actin filaments to generate motility or force. Unconventional myosins are implicated in diverse cellular processes including organelle trafficking, F-actin organization and cell movement. The unconventional myosin, myosin XVA (MYO15A), is localized at the tips of stereocilia in the inner ear hair cells and plays important roles in the development and maintenance of stereocilia. Mutations in MYO15A / Myo15a genes are responsible for hearing loss DFNB3 and shaker-2 in human and mice, respectively. In the present review, we will discuss the expression and alternative splicing of the MYO15A gene, the biochemical properties of the MYO15A protein and the association of MYO15A mutations with hearing loss. We will also discuss the recent investigations into the mechanism of how MYO15A regulates stereocilia development and maintenance. At present we are just beginning to appreciate the important roles of MYO15A in stereocilia, and further investigations are warranted to fully understand them.